Cystic fibrosis: bacterial pathogenesis and CFTR (cystic fibrosis transmembrane conductance regulator) modulators

被引:0
|
作者
Vargas-Roldan, Silvia Y. [1 ,2 ]
Lezana-Fernandez, Jose L. [3 ,4 ]
Cerna-Cortes, Jorge F. [2 ]
Partida-Sanchez, Santiago [5 ,6 ]
Santos-Preciado, Jose, I [1 ]
Rosales-Reyes, Roberto [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Fac Med, Unidad Invest Med Expt, Ciudad De Mexico, Mexico
[2] Inst Politecn Nacl, Dept Microbiol, Lab Microbiol Mol, Escuela Nacl Ciencias Biol, Ciudad De Mexico, Mexico
[3] Hosp Infantil Mexico Dr Federico Gomez, Lab Fisiol Respiratoria & Clin Fibrosis Quist, Ciudad De Mexico, Mexico
[4] Assoc Mexicana Fibrosis Quist, Direcc Med, Ciudad De Mexico, Mexico
[5] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Abigail Wexner Res Inst, Columbus, OH USA
[6] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA
来源
关键词
Cystic fibrosis; Pseudomonas aeruginosa; Burkholderia cenocepacia; CFTR modulators; VI SECRETION SYSTEM; PSEUDOMONAS-AERUGINOSA; ADAPTATION; POTENTIATOR; IVACAFTOR;
D O I
10.24875/BMHIM.21000128
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Cystic fibrosis is an autosomal recessive inherited disease caused by mutations in the cystic fibrosis transmembrane con-ductance regulator gene (CFTR). CFTR is a protein that transports ions across the membrane of lung epithelial cells. Loss of its function leads to the production of thick sticky mucus, where various bacterial pathogens can establish and adapt, contributing to the gradual loss of lung function. In this review, evidence of the molecular mechanisms used by Pseudomonas aeruginosa and Burkholderia cenocepacia to survive and persist in the pulmonary environment will be provided. Additionally, new therapeutic strategies based on CFTR function modulators will be described.
引用
收藏
页码:215 / 221
页数:7
相关论文
共 50 条
  • [1] Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis
    Parisi, Giuseppe Fabio
    Mollica, Federico
    Giallongo, Alessandro
    Papale, Maria
    Manti, Sara
    Leonardi, Salvatore
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2022, 23 (01)
  • [2] Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis
    Giuseppe Fabio Parisi
    Federico Mòllica
    Alessandro Giallongo
    Maria Papale
    Sara Manti
    Salvatore Leonardi
    Egyptian Journal of Medical Human Genetics, 23
  • [4] Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage
    Zhang, Shuzhong
    Shrestha, Chandra L.
    Kopp, Benjamin T.
    SCIENTIFIC REPORTS, 2018, 8
  • [5] Cystic fibrosis liver disease in the new era of cystic fibrosis transmembrane conductance regulator (CFTR) modulators
    Eldredge, Jessica A.
    Oliver, Mark R.
    Ooi, Chee Y.
    PAEDIATRIC RESPIRATORY REVIEWS, 2024, 50 : 54 - 61
  • [6] The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis
    Sergeev, Valentine
    Chou, Frank Y.
    Lam, Grace Y.
    Hamilton, Christopher Michael
    Wilcox, Pearce G.
    Quon, Bradley S.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2020, 17 (02) : 147 - 154
  • [7] Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosis
    Burgener, Elizabeth B.
    Moss, Richard B.
    CURRENT OPINION IN PEDIATRICS, 2018, 30 (03) : 372 - 377
  • [8] Tritherapy with cystic fibrosis transmembrane conductance regulator protein modulators in cystic fibrosis
    Colodro, Oscar Fielbaum
    Grell, Alberto Vidal
    Yarur, Alejandra Mendez
    Clerc, Camila Sobarzo
    ANDES PEDIATRICA, 2022, 93 (06): : 898 - 905
  • [9] Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function
    Shuzhong Zhang
    Chandra L. Shrestha
    Benjamin T. Kopp
    Scientific Reports, 8
  • [10] Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
    Schmidt, BeLa Z.
    Haaf, Jeremy B.
    Leal, Teresinha
    Noel, Sabrina
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2016, 8 : 127 - 140